<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Infectious disease AND Candidiasis, oral</title><link>http://www.unboundmedicine.com/medline/ebm/research/Infectious_disease/Candidiasis,_oral</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18813103/full_citation/Posaconazole_as_salvage_therapy_in_patients_with_invasive_fungal_infections_after_solid_organ_transplant_</link><description>Alexander BD, Perfect JR, Daly JS, et al. <br/><span class="title">Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant. [Journal Article]</span><br/><span class="source" title="Transplantation">Transplantation 2008 Sep 27; 86(6):791-6.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18813103/abstract/Posaconazole_as_salvage_therapy_in_patients_with_invasive_fungal_infections_after_solid_organ_transplant_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18813103/full_citation/Posaconazole_as_salvage_therapy_in_patients_with_invasive_fungal_infections_after_solid_organ_transplant_">Full Citation</a> | <a href="http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm%3fan=00007890-200809270-00008">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18813103/Posaconazole_as_salvage_therapy_in_patients_with_invasive_fungal_infections_after_solid_organ_transplant_">Find Related Articles</a> </description></item><item><title>Posaconazole for paediatric patients: status of development and future perspectives.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18721328/full_citation/Posaconazole_for_paediatric_patients:_status_of_development_and_future_perspectives_</link><description>Groll AH, Lehrnbecher T <br/><span class="title">Posaconazole for paediatric patients: status of development and future perspectives. [Journal Article]</span><br/><span class="source" title="Mycoses">Mycoses 2008 Sep.:5-11.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18721328/abstract/Posaconazole_for_paediatric_patients:_status_of_development_and_future_perspectives_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18721328/full_citation/Posaconazole_for_paediatric_patients:_status_of_development_and_future_perspectives_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18721328/Posaconazole_for_paediatric_patients:_status_of_development_and_future_perspectives_">Find Related Articles</a> </description></item><item><title>Update in infectious disease treatment.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18756840/full_citation/Update_in_infectious_disease_treatment_</link><description>Longworth DL <br/><span class="title">Update in infectious disease treatment. [Journal Article]</span><br/><span class="source" title="Cleveland Clinic journal of medicine">Cleve Clin J Med 2008 Aug; 75(8):584-90.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18756840/abstract/Update_in_infectious_disease_treatment_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18756840/full_citation/Update_in_infectious_disease_treatment_">Full Citation</a></description></item><item><title>[HIV infected child in otolaryngological practice]</title><link>http://www.unboundmedicine.com/medline/ebm/record/18637437/full_citation/[HIV_infected_child_in_otolaryngological_practice]</link><description>Smiatacz T, Narozny W, Kuczkowski J, et al. <br/><span class="title">[HIV infected child in otolaryngological practice] [English Abstract, Journal Article]</span><br/><span class="source" title="Otolaryngologia polska. The Polish otolaryngology">Otolaryngol Pol 2008; 62(2):145-8.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18637437/abstract/[HIV_infected_child_in_otolaryngological_practice]">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18637437/full_citation/[HIV_infected_child_in_otolaryngological_practice]">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18637437/[HIV_infected_child_in_otolaryngological_practice]">Find Related Articles</a> </description></item><item><title>A Phase 2, Open-Label Study of the Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18545153/full_citation/A_Phase_2_Open_Label_Study_of_the_Safety_and_Efficacy_of_Intravenous_Anidulafungin_as_a_Treatment_for_Azole_Refractory_Mucosal_Candidiasis_</link><description>Vazquez JA, Schranz JA, Clark K, et al. <br/><span class="title">A Phase 2, Open-Label Study of the Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of acquired immune deficiency syndromes (1999)">J Acquir Immune Defic Syndr 2008 Jun 9.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18545153/abstract/A_Phase_2_Open_Label_Study_of_the_Safety_and_Efficacy_of_Intravenous_Anidulafungin_as_a_Treatment_for_Azole_Refractory_Mucosal_Candidiasis_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18545153/full_citation/A_Phase_2_Open_Label_Study_of_the_Safety_and_Efficacy_of_Intravenous_Anidulafungin_as_a_Treatment_for_Azole_Refractory_Mucosal_Candidiasis_">Full Citation</a></description></item><item><title>Predictors of mortality in patients initiating antiretroviral therapy in Durban, South Africa.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18350223/full_citation/Predictors_of_mortality_in_patients_initiating_antiretroviral_therapy_in_Durban_South_Africa_</link><description>Ojikutu BO, Zheng H, Walensky RP, et al. <br/><span class="title">Predictors of mortality in patients initiating antiretroviral therapy in Durban, South Africa. [Journal Article]</span><br/><span class="source" title="South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde">S Afr Med J 2008 Mar; 98(3):204-8.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18350223/abstract/Predictors_of_mortality_in_patients_initiating_antiretroviral_therapy_in_Durban_South_Africa_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18350223/full_citation/Predictors_of_mortality_in_patients_initiating_antiretroviral_therapy_in_Durban_South_Africa_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18350223/Predictors_of_mortality_in_patients_initiating_antiretroviral_therapy_in_Durban_South_Africa_">Find Related Articles</a> </description></item><item><title>Reviews Of Anti-infective Agents: Posaconazole: A Broad-Spectrum Triazole Antifungal Agent.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18190324/full_citation/Reviews_Of_Anti_infective_Agents:_Posaconazole:_A_Broad_Spectrum_Triazole_Antifungal_Agent_</link><description>Nagappan V, Deresinski S <br/><span class="title">Reviews Of Anti-infective Agents: Posaconazole: A Broad-Spectrum Triazole Antifungal Agent. [Journal Article]</span><br/><span class="source" title="Clinical infectious diseases : an official publication of the Infectious Diseases Society of America">Clin Infect Dis 2007 Dec 15; 45(12):1610-7.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18190324/abstract/Reviews_Of_Anti_infective_Agents:_Posaconazole:_A_Broad_Spectrum_Triazole_Antifungal_Agent_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18190324/full_citation/Reviews_Of_Anti_infective_Agents:_Posaconazole:_A_Broad_Spectrum_Triazole_Antifungal_Agent_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18190324/Reviews_Of_Anti_infective_Agents:_Posaconazole:_A_Broad_Spectrum_Triazole_Antifungal_Agent_">Find Related Articles</a> </description></item><item><title>The buccale puzzle: The symbiotic nature of endogenous infections of the oral cavity.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18159372/full_citation/The_buccale_puzzle:_The_symbiotic_nature_of_endogenous_infections_of_the_oral_cavity_</link><description>Ruby J, Barbeau J <br/><span class="title">The buccale puzzle: The symbiotic nature of endogenous infections of the oral cavity. [JOURNAL ARTICLE]</span><br/><span class="source" title="">Can J Infect Dis 2002 1; 13(1):34-41.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18159372/abstract/The_buccale_puzzle:_The_symbiotic_nature_of_endogenous_infections_of_the_oral_cavity_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18159372/full_citation/The_buccale_puzzle:_The_symbiotic_nature_of_endogenous_infections_of_the_oral_cavity_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18159372/The_buccale_puzzle:_The_symbiotic_nature_of_endogenous_infections_of_the_oral_cavity_">Find Related Articles</a> </description></item><item><title>Targeted gene deletion in Candida parapsilosis demonstrates the role of secreted lipase in virulence.</title><link>http://www.unboundmedicine.com/medline/ebm/record/17853941/full_citation/Targeted_gene_deletion_in_Candida_parapsilosis_demonstrates_the_role_of_secreted_lipase_in_virulence_</link><description>Gácser A, Trofa D, Schäfer W, et al. <br/><span class="title">Targeted gene deletion in Candida parapsilosis demonstrates the role of secreted lipase in virulence. [JOURNAL ARTICLE]</span><br/><span class="source" title="">J Clin Invest 2007 Oct 1; 117(10):3049-3058.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/17853941/abstract/Targeted_gene_deletion_in_Candida_parapsilosis_demonstrates_the_role_of_secreted_lipase_in_virulence_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/17853941/full_citation/Targeted_gene_deletion_in_Candida_parapsilosis_demonstrates_the_role_of_secreted_lipase_in_virulence_">Full Citation</a> | <a href="http://www.jci.org/cgi/pmidlookup%3fview=long%26amp;pmid=17853941">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/17853941/Targeted_gene_deletion_in_Candida_parapsilosis_demonstrates_the_role_of_secreted_lipase_in_virulence_">Find Related Articles</a> </description></item><item><title>Oral mucosa alterations in chronic hepatitis and cirrhosis due to HBV or HCV infection.</title><link>http://www.unboundmedicine.com/medline/ebm/record/17672199/full_citation/Oral_mucosa_alterations_in_chronic_hepatitis_and_cirrhosis_due_to_HBV_or_HCV_infection_</link><description>Sulka A, Simon K, Piszko P, et al. <br/><span class="title">Oral mucosa alterations in chronic hepatitis and cirrhosis due to HBV or HCV infection. [Journal Article]</span><br/><span class="source" title="Bulletin du Groupement international pour la recherche scientifique en stomatologie &amp; odontologie">Bull Group Int Rech Sci Stomatol Odontol 2006 Mar; 47(1):6-10.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/17672199/abstract/Oral_mucosa_alterations_in_chronic_hepatitis_and_cirrhosis_due_to_HBV_or_HCV_infection_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/17672199/full_citation/Oral_mucosa_alterations_in_chronic_hepatitis_and_cirrhosis_due_to_HBV_or_HCV_infection_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/17672199/Oral_mucosa_alterations_in_chronic_hepatitis_and_cirrhosis_due_to_HBV_or_HCV_infection_">Find Related Articles</a> </description></item></channel></rss>